< Terug naar vorige pagina
Onderzoeker
Dahham Alsoud
- Disciplines:Gastro-enterologie
Affiliaties
- Translationeel Onderzoek van Gastro-enterologische Aandoeningen (TARGID) (Afdeling)
Lid
Vanaf15 sep 2019 → Heden
Projecten
1 - 1 of 1
- "Het voorspellen van therapie respons bij inflammatoire darmziekten "Vanaf23 sep 2019 → HedenFinanciering: Eigen Middelen zoals patrimonium, inschrijvingsgelden, giften, ....
Publicaties
1 - 6 van 6
- Letter: immunogenicity is not the root cause for loss of response to anti-TNF agents in patients with IBD in TDM era(2022)
Auteurs: Dahham Alsoud, Bram Verstockt
Pagina's: 885 - 886Aantal pagina's: 2 - Biomarker discovery for personalized therapy selection in inflammatory bowel diseases: Challenges and promises.(2022)
Auteurs: Dahham Alsoud, Séverine Vermeire, Bram Verstockt
Pagina's: 100089 - Breaking the therapeutic ceiling in drug development in ulcerative colitis(2021)
Auteurs: Dahham Alsoud, Bram Verstockt, Séverine Vermeire
Pagina's: S89 - S95Aantal pagina's: 7 - The effect of aging on infliximab exposure and response in patients with inflammatory bowel diseases(2021)
Auteurs: Wannee Kantasiripitak, Bram Verstockt, Dahham Alsoud, Debby Thomas, Séverine Vermeire, Marc Ferrante, Erwin Dreesen
Pagina's: 3776 - 3789Aantal pagina's: 14 - Monitoring vedolizumab and ustekinumab drug levels in patients with inflammatory bowel disease: hype or hope?(2020)
Auteurs: Dahham Alsoud, Séverine Vermeire, Bram Verstockt
Pagina's: 17 - 30Aantal pagina's: 14 - A MUCOSAL MARKER PREDICTING TOFACITINIB INDUCED ENDOSCOPIC RESPONSE IN ULCERATIVE COLITIS(2020)
Auteurs: Bram Verstockt, Sare Verstockt, Dahham Alsoud, João Pedro Guedelha Sabino, Marc Ferrante, Séverine Vermeire
Pagina's: S688 - S689Aantal pagina's: 2